{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T12:03:15Z","timestamp":1751198595565},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"S4","license":[{"start":{"date-parts":[[1987,12,1]],"date-time":"1987-12-01T00:00:00Z","timestamp":565315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1987,12,1]],"date-time":"1987-12-01T00:00:00Z","timestamp":565315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1987,12]]},"DOI":"10.1007\/bf00207265","type":"journal-article","created":{"date-parts":[[2004,9,3]],"date-time":"2004-09-03T03:31:46Z","timestamp":1094182306000},"page":"S65-S75","source":"Crossref","is-referenced-by-count":3,"title":["Alpha interferon: a look to the future"],"prefix":"10.1007","volume":"5","author":[{"given":"Eric M.","family":"Bonnem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00207265_CR1","unstructured":"Krown SE, Real FX, Cunningham-Rundles S: Kaposi's sarcoma and immunodeficiency in homosexual men: response to recombinant leukocyte A interferon. Third Annual International Congress for Interferon Research, Miami, No. 30, 1982"},{"key":"BF00207265_CR2","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJM198305053081806","volume":"308","author":"SE Krown","year":"1983","unstructured":"Krown SE, Real FX, Cunningham-Rundles S: Preliminary observations on the effects of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma. N Eng J Med 308:1071\u20131076, 1983","journal-title":"N Eng J Med"},{"key":"BF00207265_CR3","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1200\/JCO.1986.4.4.544","volume":"4","author":"FX Real","year":"1986","unstructured":"Real FX, Oettgen HF, Krown S: Kaposi's sarcoma and the acquired immunodeficiency syndrome. Treatment with high and low doses of recombinant leucocyte A interferon. J Clin Oncol 4:544\u2013551, 1986","journal-title":"J Clin Oncol"},{"key":"BF00207265_CR4","first-page":"118a","volume":"62","author":"P Volberding","year":"1983","unstructured":"Volberding P, Moran T, Abrams D: Recombinant alpha interferon therapy of Kaposi's sarcoma in acquired immunodeficiency syndrome. Am Soc Hematol 62:118a, 1983","journal-title":"Am Soc Hematol"},{"key":"BF00207265_CR5","first-page":"53","volume":"2","author":"P Volberding","year":"1983","unstructured":"Volberding P, Gotlieb M, Rothaman J: Therapy of Kaposi's sarcoma in acquired immune deficiency syndrome (AIDS) with recombinant \u03b12-interferon. Am Soc Clin Oncol 2:53, 1983","journal-title":"Am Soc Clin Oncol"},{"key":"BF00207265_CR6","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1200\/JCO.1985.3.4.506","volume":"3","author":"A Rios","year":"1986","unstructured":"Rios A, Mansell PW, Newell GR: Treatment of acquired immunodeficiency syndrome related Kaposi's sarcoma with lymphoblastoid interferon. J Clin Oncol 3:506\u2013512, 1986","journal-title":"J Clin Oncol"},{"key":"BF00207265_CR7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0002-9343(85)90276-1","volume":"78","author":"EP Gelmann","year":"1985","unstructured":"Gelmann EP, Preble OT, Steis R: Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immunodeficiency syndrome. Am J Med 78:737\u2013741, 1985","journal-title":"Am J Med"},{"key":"BF00207265_CR8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00000421-198204000-00064","volume":"5","author":"N Einhorn","year":"1982","unstructured":"Einhorn N, Cantell K, Einhorn S, Strander H: Human leukocyte interferon therapy for advanced ovarian carcinoma. Am J Clin Oncol 5:167\u2013172, 1982","journal-title":"Am J Clin Oncol"},{"key":"BF00207265_CR9","first-page":"133","volume":"2","author":"RS Freedman","year":"1983","unstructured":"Freedman RS, Gutterman JU, Wharton JT: Leucocyte interferon in patients with epithelial ovarian carcinoma. J Biol Resp Mod 2:133\u2013138, 1983","journal-title":"J Biol Resp Mod"},{"key":"BF00207265_CR10","first-page":"221","volume":"5","author":"C Welander","year":"1986","unstructured":"Welander C, Homesley H, Levein E: Phase II trial of the efficiency of human recombinant interferon gamma in recurrent ovarian carcinoma. Proc Am Soc Clin Oncol 5:221, 1986","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00207265_CR11","first-page":"4447","volume":"44","author":"JS Berek","year":"1985","unstructured":"Berek JS, Hacker NF, Lichtenstein A: Intraperitoneal recombinant interferon for salvage immunotherapy in Stage III epithelial ovarian cancer. Cancer Res 44:4447\u20134453, 1985","journal-title":"Cancer Res"},{"key":"BF00207265_CR12","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/1097-0142(19850715)56:2<294::AID-CNCR2820560216>3.0.CO;2-K","volume":"56","author":"A Rimbaldi","year":"1985","unstructured":"Rimbaldi A, Introna M: Intraperitoneal administration of interferon beta in ovarian cancer patients. Cancer 56:294\u2013301, 1985","journal-title":"Cancer"},{"key":"BF00207265_CR13","first-page":"634","volume":"41","author":"HO Hill","year":"1981","unstructured":"Hill HO, Pardue A, Khan A: Clinical trials of human leukocyte interferon in malignancy. Tex Rep Biol Med 41:634\u2013640, 1981","journal-title":"Tex Rep Biol Med"},{"key":"BF00207265_CR14","first-page":"1022","volume":"1","author":"D Ikic","year":"1981","unstructured":"Ikic D, Maricic Z, Oresic V: Application of human leukocyte interferon in patients with urinary bladder papillomatosis, breast cancer and melanoma. Lancet 1:1022, 1981","journal-title":"Lancet"},{"key":"BF00207265_CR15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/jir.1982.2.339","volume":"2","author":"CH Scorticatti","year":"1982","unstructured":"Scorticatti CH, de la Pena NC, Bellora OG: Systemic interferon-alpha treatment of multiple bladder papilloma grade I or II patients: pilot study. J Interferon Res 2:339\u2013343, 1982","journal-title":"J Interferon Res"},{"key":"BF00207265_CR16","unstructured":"Torti FM, Shortlife LD, Williams RD: Superficial bladder cancers are responsive to alpha-2 interferon administered intravesically. Proc Am Soc Clin Oncol 3\u2013160, 1984"},{"issue":"6","key":"BF00207265_CR17","first-page":"608","volume":"29","author":"M Nagai","year":"1983","unstructured":"Nagai M, Arai T, Kohno S, Iizuka E: Current status of interferon therapy on malignant brain tumor. Dept. of neurosurgery, Kokkyo Univ. School of Med. Gan No Rinsho (Japan) 29 (6): 608\u2013615, 1983","journal-title":"Dept. of neurosurgery, Kokkyo Univ. School of Med. Gan No Rinsho (Japan)"},{"key":"BF00207265_CR18","first-page":"229","volume":"4","author":"M Mahaley","year":"1985","unstructured":"Mahaley M, Urso M, Whaley R, Selker R, Williams T, Guaspari A. Malignant glioma treatment with interferons. Proc Am Soc Clin Oncol 4:229, 1985","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00207265_CR19","first-page":"212a","volume":"62","author":"R Ferraresi","year":"1983","unstructured":"Ferraresi R, Rudnick SA, Bonnem EM: Enhanced response to chemotherapy after treatment with DNA alpha-2 interferon. Blood (Suppl) 62:212a, 1983","journal-title":"Blood (Suppl)"},{"key":"BF00207265_CR20","first-page":"188a","volume":"62","author":"RH Clark","year":"1983","unstructured":"Clark RH, Dimitrov NV, Axelson JA: Leucocyte interferon as a biological modifier in lymphoproliferative diseases resistant to standard therapy. Blood (Suppl) 62:188a, 1983","journal-title":"Blood"},{"key":"BF00207265_CR21","first-page":"613","volume":"3","author":"RH Clark","year":"1984","unstructured":"Clark RH, Dimitrov NV, Axelson JA: Leucocyte interferon as a possible biological response modifier in lymphoproliferative disorders resistant to standard therapy. J Biol Resp Mod 3:613\u2013619, 1984","journal-title":"J Biol Resp Mod"},{"key":"BF00207265_CR22","first-page":"473","volume":"70","author":"MR Cooper","year":"1986","unstructured":"Cooper MR, Fefer A, Thompson J: Alpha-2 interferon\/ melphalan\/prednisone in previously untreated patients with multiple myeloma: A Phase I\u2013II trial. Cancer Treat Rep 70:473\u2013476, 1986","journal-title":"Cancer Treat Rep"},{"key":"BF00207265_CR23","first-page":"228","volume":"5","author":"L Clouse","year":"1986","unstructured":"Clouse L, Braich T, Grimm M: A Phase I trial of oral cyclophosphamide and subcutaneous alpha-2b interferon in patients with malignant disease. Proc Am Soc Clin Oncol 5:228, 1986","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00207265_CR24","first-page":"220","volume":"4","author":"CE Welander","year":"1985","unstructured":"Welander CE, Muss HB, Homesley HD: Phase II trial of combined human interferon alpha-2 and doxorubicin. Proc Am Soc Clin Oncol 4:220, 1985","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00207265_CR25","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ijc.2910350605","volume":"35","author":"CE Welander","year":"1985","unstructured":"Welander CE, Muss HB, Homesley HD: Phase II trial of combined human interferon alpha-2 and doxorubicin. Int J Cancer 35:721\u2013729, 1985","journal-title":"Int J Cancer"},{"key":"BF00207265_CR26","first-page":"49","volume":"3","author":"RA Figlin","year":"1984","unstructured":"Figlin RA, De Kernion JB, Maldazys J: Human leukocyte interferon\/vinblastine therapy for renal cell carcinoma. Proc Am Soc Clin Oncol 3:49, 1984","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00207265_CR27","first-page":"101","volume":"4","author":"R Ravdin","year":"1985","unstructured":"Ravdin R, Tuttle R, Davis TE, Trump DL: Phase I\u2013II trial of human lymphoblastoid interferon and continuous infusion vinblastine in advanced renal cell cancer. Proc Am Soc Clin Oncol 4:101, 1985","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00207265_CR28","first-page":"110","volume":"5","author":"GL Getto","year":"1986","unstructured":"Getto GL, Franceschi T, Bassetto MA: Phase I\/II trial of recombinant alpha-2-IFN and vinblastine in metastatic renal cell carcinoma. Proc Am Soc Clin Oncol 5:110, 1986","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00207265_CR29","first-page":"6","volume":"4","author":"A Rios","year":"1985","unstructured":"Rios A, Mansell P, Newell G: The use of lymphoblastoid interferon and vinblastine in the treatment of acquired immunodeficiency syndrome related Kaposi's sarcoma. Proc Am Soc Clin Oncol 4:6, 1985","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00207265_CR30","first-page":"2","volume":"4","author":"M Lonberg","year":"1985","unstructured":"Lonberg M, Odajnyk C, Krigel R: Sequential and simultaneous alpha-2 interferon and VP-16 in epidemic Kaposi's sarcoma. Proc Am Soc Clin Oncol 4:2, 1985","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00207265_CR31","first-page":"146","volume":"3","author":"PFM Wrigley","year":"1984","unstructured":"Wrigley PFM, Slevin ML, Clark P: Alpha-2 interferon in combination with 5-fluorouracil for advanced colorectal carcinoma. Proc Am Soc Clin Oncol 3:146, 1984","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00207265_CR32","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1001\/jama.1982.03320370032025","volume":"247","author":"SJ Horning","year":"1982","unstructured":"Horning SJ, Levine JF, Miller RA: Clinical and immunological effects of recombinant leukocyte A interferon in eight patients with advanced cancer. JAMA 247:1718\u20131722, 1982","journal-title":"JAMA"},{"key":"BF00207265_CR33","first-page":"141","volume":"4","author":"FX Real","year":"1985","unstructured":"Real FX, Krown SE, Nisce LZ, Oettgen HF: Unexpected toxicity from radiation therapy in two patients with Kaposi's sarcoma receiving interferon. J Biol Resp Mod 4:141\u2013146, 1985","journal-title":"J Biol Resp Mod"},{"key":"BF00207265_CR34","first-page":"227","volume":"4","author":"J Torrisi","year":"1985","unstructured":"Torrisi J, Berg C, Harter K: Phase I combined modality trial of alpha-2 interferon and radiotherapy. Proc Am Soc Clin Oncol 4:227, 1985","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00207265_CR35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1128\/iai.26.1.248-253.1979","volume":"26","author":"WR Fleischmann","year":"1979","unstructured":"Fleischmann WR, Georgiades JA, Osborne LC: Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon. Infect Immun 26:248\u2013253, 1979","journal-title":"Infect Immun"},{"key":"BF00207265_CR36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0166-3542(82)90045-6","volume":"2","author":"A Zerial","year":"1982","unstructured":"Zerial A, Hovanessian AG, Stefanos S: Synergistic activities of type I (\u03b1, \u03b2) and type II (\u03b3) murine interferons. Antiviral Res 2:227\u2013239, 1982","journal-title":"Antiviral Res"},{"key":"BF00207265_CR37","first-page":"608","volume":"3","author":"LA Schwarz","year":"1984","unstructured":"Schwarz LA, Fleischmann CM, Fleischmann WR: Potentiation of interferon's antiviral activity by the mutually synergistic interaction of Mu IFN \u03b1\/\u03b2 and Mu IFN-\u03b3. J Biol Resp Mod 3:608\u2013612, 1984","journal-title":"J Biol Resp Mod"},{"key":"BF00207265_CR38","first-page":"869","volume":"42","author":"WR Fleischmann","year":"1982","unstructured":"Fleischmann WR: Potentiation of direct anticellular activity of mouse interferon: mutual synergism and interferon concentration dependence. Cancer Res 42:869\u2013875, 1982","journal-title":"Cancer Res"},{"key":"BF00207265_CR39","first-page":"963","volume":"65","author":"WR Fleischmann Jr","year":"1980","unstructured":"Fleischmann WR Jr, Kleyn KM, Baron S: Potentiation of antitumor effect of virus induced interferon by mouse immune interferon preparations. J Natl Cancer Inst 65:963\u20131066, 1980","journal-title":"J Natl Cancer Inst"},{"key":"BF00207265_CR40","first-page":"377","volume":"44","author":"TL Ratcliff","year":"1984","unstructured":"Ratcliff TL, Kadmon D, Shapiro A: Inhibition of mouse bladder tumor proliferation by murine interferon-\u03b3 and its synergism with interferon \u03b2. Cancer Res 44:377\u20134381, 1984","journal-title":"Cancer Res"},{"key":"BF00207265_CR41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0166-3542(84)90020-2","volume":"4","author":"WR Fleischmann Jr","year":"1984","unstructured":"Fleischmann WR Jr, Fleischmann CM: Potentiating effect of murine interferon-\u03b3 containing lymphokine preparations on the antiviral and antiproliferative effects of murine interferon \u03b1\/\u03b2: identification of the potentiation factor as murine interferon-\u03b3 itself. Antiviral Res 4:221\u2013228, 1984","journal-title":"Antiviral Res"},{"key":"BF00207265_CR42","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0042-6822(83)90101-0","volume":"130","author":"CE Samuel","year":"1983","unstructured":"Samuel CE, Knutson GS: Mechanism of interferon action: human leukocyte and immune interferons regulate the expression of different genes and induce different antiviral states of human amnion U cells. Virology 130:474\u2013484, 1983","journal-title":"Virology"},{"key":"BF00207265_CR43","first-page":"361","volume":"5","author":"E Oleszak","year":"1985","unstructured":"Oleszak E, Stewart WE: Potentiation of the antiviral and anticellular activities of interferons by mixtures of Hu IFN-\u03b3 and Hu IFN \u03b1 or Hu IFN \u03b2. J Inf Res 5:361\u2013371, 1985","journal-title":"J Inf Res"},{"key":"BF00207265_CR44","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0166-3542(84)90007-X","volume":"4","author":"WR Fleischmann Jr","year":"1984","unstructured":"Fleischmann WR Jr, Fleischmann CM, Friers W: Potentiation of interferon action by mixtures of recombinant DNA derived human interferons. Antiviral Res 4:357\u2013360, 1984","journal-title":"Antiviral Res"},{"key":"BF00207265_CR45","first-page":"147","volume":"5","author":"H Denz","year":"1985","unstructured":"Denz H, Lechleitner M, March C: Effect of human recombinant alpha-2 and gamma interferon on the growth of human cell lines from solid tumors and hematologic malignancies. J Inf Res 5:147\u2013157, 1985","journal-title":"J Inf Res"},{"key":"BF00207265_CR46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/iai.40.1.35-38.1983","volume":"40","author":"DA Weigent","year":"1983","unstructured":"Weigent DA, Langford MP, Fleischmann WR Jr: Potentiation of natural killing by mixtures of alpha or beta interferon with recombinant gamma interferon. Infect Immun 40:35\u201338, 1983","journal-title":"Infect Immun"},{"issue":"2","key":"BF00207265_CR47","first-page":"83","volume":"3","author":"RJ Chang","year":"1984","unstructured":"Chang RJ, Assisi F, Lee SH: The synergistic stimulation of the expression of Fc-receptors for immunoglobulin-G on a monocyte like cell line by gamma interferon and a human lymphotoxin. Lymphokine Res 3 (2): 83, 1984","journal-title":"Lymphokine Res"},{"key":"BF00207265_CR48","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ijc.2910340411","volume":"34","author":"J Le","year":"1984","unstructured":"Le J, Yip YK, Vilcek J: Cytolytic activity of interferon gamma and its synergism with 5-fluorouracil. Int J Cancer 34:495\u2013500, 1984","journal-title":"Int J Cancer"},{"key":"BF00207265_CR49","first-page":"1056","volume":"12","author":"N Hirabayshi","year":"1985","unstructured":"Hirabayshi N, Nishiyama M, Yamaguchi M: Assessment of the combined effects of mitomycin C with alpha interferon or gamma interferon by the clonagenic assay technique. Gan To Kagaku Ryoho 12:1056\u20131062, 1985","journal-title":"Gan To Kagaku Ryoho"},{"key":"BF00207265_CR50","first-page":"281","volume":"26","author":"AYC Chang","year":"1985","unstructured":"Chang AYC, Keng PC: Effects of gamma interferon and radiation on synchronized human hypernephroma cells. Proc Am Assoc Cancer Res 26:281, 1985","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF00207265_CR51","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1073\/pnas.80.17.5397","volume":"80","author":"BD Williamson","year":"1983","unstructured":"Williamson BD, Carswell EA, Rubin BY: Human tumor necrosis factor produced by human B cell lines; synergistic cytotoxic interaction with human interferon. Proc Natl Acad Sci 80:5397\u20135401, 1983","journal-title":"Proc Natl Acad Sci"},{"key":"BF00207265_CR52","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.4049\/jimmunol.136.7.2441","volume":"136","author":"M Tsujimoto","year":"1986","unstructured":"Tsujimoto M, Yip YK, Vilcek J: Interferon enhances expression of cellular receptors for tumor necrosis factor. J Immunol 136:2441\u20132444, 1986","journal-title":"J Immunol"},{"key":"BF00207265_CR53","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1126\/science.3933111","volume":"230","author":"BJ Sugarman","year":"1985","unstructured":"Sugarman BJ, Aggarwal BB, Haas PE: Recombinant human tumor necrosis factor: effects on proliferation of normal and transformed cells in vitro. Science 230:943\u2013945, 1985","journal-title":"Science"},{"key":"BF00207265_CR54","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.4049\/jimmunol.133.3.1083","volume":"133","author":"SH Lee","year":"1984","unstructured":"Lee SH, Aggarwal B, Rinderknecht E: The synergistic antiproliferative effect of \u03b1-interferon and human lymphotoxin. J Immunol 133:1083\u20131086, 1984","journal-title":"J Immunol"},{"key":"BF00207265_CR55","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/0006-2952(84)90117-5","volume":"33","author":"SH Lee","year":"1984","unstructured":"Lee SH, Chiu H, Renton KW: Modulation by a human interferon of antitumor effects of cyclophosphamide against lymphosarcoma in hamsters. Biochem Pharmacol 33:3439\u20133443, 1984","journal-title":"Biochem Pharmacol"},{"key":"BF00207265_CR56","first-page":"904","volume":"44","author":"FR Balkwill","year":"1984","unstructured":"Balkwill FR, Moodie EM: Positive interactions between human interferon and cyclophosphamide or Adriamycin in a human tumor model. Cancer Res 44:904\u2013908, 1984","journal-title":"Cancer Res"},{"key":"BF00207265_CR57","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00255753","volume":"10","author":"MS Aapro","year":"1983","unstructured":"Aapro MS, Alberts DS, Salmon S: Interactions of human leukocyte interferon with vinca alkaloids of other chemotherapeutic agents against human tumors in clonagenic assay. Cancer Chemother Pharmacol 10:161\u2013166, 1983","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF00207265_CR58","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ijc.2910340411","volume":"34","author":"L Junming","year":"1984","unstructured":"Junming L, Yip YK, Vilcek J: Cytolytic activity of interferon gamma and its synergism with 5-fluorouracil. Int J Cancer 34:495\u2013500, 1984","journal-title":"Int J Cancer"},{"key":"BF00207265_CR59","first-page":"2207","volume":"9","author":"T Miyoshi","year":"1982","unstructured":"Miyoshi T, Ogawa S, Kanamori T: Combined effects of 5-fluorouracil and interferon on proliferation of human neoplastic cells in culture. Gan To Kagaku Ryoho 9:2207\u20132211, 1982","journal-title":"Gan To Kagaku Ryoho"},{"key":"BF00207265_CR60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0304-3835(83)90041-1","volume":"20","author":"S Yamamoto","year":"1983","unstructured":"Yamamoto S, Tanaka H, Kanamori T: In vitro studies on potentiation of cytotoxic effects of anticancer drugs by interferon on a human neoplastic cell line. Cancer Lett 20:131\u2013138, 1983","journal-title":"Cancer Lett"},{"key":"BF00207265_CR61","first-page":"391","volume":"4","author":"LM Wolf","year":"1985","unstructured":"Wolf LM, Leitzel KE, Pegg AE: The in vitro interaction of alpha-difluoromethyl ornithine in several interferons on human cell lines. J Biol Resp Mod 4:391\u2013395, 1985","journal-title":"J Biol Resp Mod"},{"key":"BF00207265_CR62","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ijc.2910350605","volume":"34","author":"CE Welander","year":"1985","unstructured":"Welander CE, Morgan TM, Homesley HD: Combined recombinant human interferon alpha-2 and cytotoxic agents. Int J Cancer 34:721\u2013729, 1985","journal-title":"Int J Cancer"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00207265.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00207265\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00207265","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00207265.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T17:39:45Z","timestamp":1678556385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00207265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,12]]},"references-count":62,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[1987,12]]}},"alternative-id":["BF00207265"],"URL":"https:\/\/doi.org\/10.1007\/bf00207265","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,12]]}}}